Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12615000829516
ACTRN12615000829516
Active, not recruiting
Phase 1

A phase 1 study of acceptability and preferences of vaporised nicotine replacement products [18mg/mL nicotine administered by vaporisers (Innokin iTaste VV4 and Cool Fire IV)] compared to standard nicotine replacement products (gum, patch, dissolvable oral strip, mouthspray, inhalator)] or vaporised nicotine-free solution [0% nicotine] in smokers living with HIV.

The University of Queensland0 sites15 target enrollmentAugust 11, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTobacco DependenceMental Health - AddictionInfection - Acquired immune deficiency syndrome (AIDS / HIV)

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Tobacco Dependence
Sponsor
The University of Queensland
Enrollment
15
Status
Active, not recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 11, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •HIV Positive, currently smoking a minimum of 5 tobacco cigarettes per day, aged 18\+, sufficiently proficient in English to provide informed consent and to complete questionnaires, not planning to quit smoking in the next month.

Exclusion Criteria

  • •Exclusion criteria includes, individuals who are;
  • •\* pregnant
  • •\* breastfeeding
  • •\* less than 18 years of age
  • •Individuals who have any of the following will require clearance from a medical practitioner in order to enrol in the study:
  • •\* have had a stroke or heart attack or severe angina in the last two weeks
  • •\* poorly controlled high blood pressure
  • •\* a mental health/psychiatric condition that is being treated with anti\-psychotic medication
  • •\* overactive thyroid
  • •\* adrenal gland tumour

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
ACceptability of long-acting ART in Cognitive ImpAirment (ACACIA)People living with HIV who have a cognitive impairmentMental and Behavioural Disorders
ISRCTN14933807niversity of Sussex20
Completed
Not Applicable
A survey to assess how user-friendly is the mobile phone app created to help people quit tobaccoHealth Condition 1: Z789- Other specified health status
CTRI/2023/08/056661FTB COLAB PRIVATE LIMITED100
Completed
Not Applicable
on-randomised pilot study of a text message self-management support programme for people with diabetesdiabetesMetabolic and Endocrine - Diabetes
ACTRN12615000277549Waitemata District Health Board40
Not yet recruiting
Phase 1
A pilot trial to assess the effectiveness and acceptability of Acceptance and Commitment Therapy among patients with Alcohol Use Disorder registered in Drug De-addiction OPD, PGIMER, Chandigarh, 2020-2022.Health Condition 1: F102- Alcohol dependence
CTRI/2021/06/034199isha
Active, not recruiting
Phase 1
To assess ease of use, acceptability and preference of Norditropin NordiFlex® in subjects on prescribed growth hormone therapychildren aged 6 years or more receiving growth hormone therapy for the following approved indications (according to Norditropine SPC)-GHD-Turner Syndrome-small for gestational age-chronic renal insufficiency
EUCTR2009-017387-16-FRovo Nordisk Pharmaceutique S.A.S